BioCryst Pharmaceuticals
BCRX
#4717
Rank
โ‚ฌ1.50 B
Marketcap
7,25ย โ‚ฌ
Share price
1.43%
Change (1 day)
56.07%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total debt

Total debt on the balance sheet as of September 2024 : โ‚ฌ0.75 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total debt is โ‚ฌ0.75 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

BioCryst Pharmaceuticals - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31โ‚ฌ0.74 B7.99%
2022-12-31โ‚ฌ0.69 B31.95%
2021-12-31โ‚ฌ0.52 B130.52%
2020-12-31โ‚ฌ0.22 B200.71%
2019-12-31โ‚ฌ75.56 M39.83%
2018-12-31โ‚ฌ54.04 M18.49%
2017-12-31โ‚ฌ45.6 M-10.71%
2016-12-31โ‚ฌ51.07 M85.05%
2015-12-31โ‚ฌ27.6 M11.9%
2014-12-31โ‚ฌ24.66 M13.55%
2013-12-31โ‚ฌ21.72 M-4.22%
2012-12-31โ‚ฌ22.67 M-1.82%
2011-12-31โ‚ฌ23.1 M
2000-12-31โ‚ฌ0.01 M
1997-12-31โ‚ฌ0.08 M-66.67%
1996-12-31โ‚ฌ0.25 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚ฌ0.69 B-8.19%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.30 B 72.72%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.39 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.21 B-71.17%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ21.77 B 2,785.79%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.87 M-99.62%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ20.03 B 2,556.18%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ0.80 B 6.56%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ11.31 M-98.50%๐Ÿ‡บ๐Ÿ‡ธ USA